Related Experiment Video
Updated: Jun 22, 2026
14:23
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates
Dawn M Dudley1, Yong Gao, Kenneth N Nelson
1Department of Molecular Biology and Microbiology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA.
Biotechniques
|June 2, 2009
Summary
This study introduces a novel yeast recombination method for cloning diverse human immunodeficiency virus 1 (HIV-1) strains, enabling better vaccine development and drug sensitivity research. This approach overcomes limitations of traditional cloning for studying clinical HIV-1 isolates.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Replication studies for human immunodeficiency virus 1 (HIV-1) are limited by the use of a few divergent laboratory strains.
- Phenotypic variations among dominant HIV-1 subtypes impact vaccine development and treatment strategies.
- Existing cloning and virus production systems are insufficient for studying drug sensitivity, replication kinetics, or personalized vaccines due to HIV-1 heterogeneity.
Purpose of the Study:
- To develop a robust cloning and virus production system for diverse HIV-1 isolates and subtypes.
- To overcome the limitations of traditional bacterial cloning methods caused by extreme HIV-1 genetic heterogeneity.
- To facilitate research on drug sensitivity, replication kinetics, and personalized vaccine development for HIV-1.
Main Methods:
- A novel yeast recombination technique was employed for direct introduction of HIV-1 coding regions into an HIV-1 DNA vector.
- The method utilizes positive and negative selectable markers in yeast, eliminating the need for DNA substrate purification and screening.
- Replication-competent virus was produced from a modified 293T packaging cell line transfected with the yeast-derived HIV-1 vector.
Main Results:
- The yeast recombination system successfully cloned diverse HIV-1 coding regions, including those from patient samples.
- The method bypasses the need for restriction enzyme sites, addressing challenges posed by HIV-1 heterogeneity.
- Replication-competent viruses were efficiently produced using the novel cloning strategy.
Conclusions:
- This yeast-based cloning strategy provides a versatile alternative for producing replication-competent viruses from diverse HIV-1 isolates.
- The technique enhances the study of drug sensitivity, replication kinetics, and personalized vaccine development for HIV-1.
- The methodology is adaptable for other diverse viral species, including hepatitis C virus and influenza virus.
